Decision-Grade Data for Critical Programs
Focused solutions addressing the most challenging areas of drug development where human-relevant data makes the difference.
Inhalation & Lung
Human-relevant respiratory models for inhaled therapeutics, toxicology, and disease modeling.
The Decision Problem
Inhaled drug development faces unique challenges in predicting human respiratory responses from traditional models.
Current Shortcoming
Animal respiratory systems differ significantly from human airways, leading to poor translation of efficacy and safety data.
How We Enable
Our lung platform provides physiologically relevant exposure conditions, dynamic airway modeling, and comprehensive endpoint analysis for confident development decisions.
Key Capabilities
IND-Enabling Decision Support
Structured data packages designed to support regulatory submissions and go/no-go decisions.
The Decision Problem
IND-enabling studies require data that regulators can evaluate and trust for human safety predictions.
Current Shortcoming
Traditional preclinical packages often lack the human relevance and reproducibility needed for confident regulatory decisions.
How We Enable
We provide decision-grade data with clear documentation, reproducible methodologies, and formats aligned with regulatory expectations.
Key Capabilities
Complex Systems & CNS
Addressing the translational gap in neurological and multi-organ disease contexts.
The Decision Problem
CNS drug development has the highest failure rate in the industry due to poor blood-brain barrier and neurological modeling.
Current Shortcoming
Current in vitro models fail to capture the complexity of the neurovascular unit and CNS disease mechanisms.
How We Enable
Our CNS-ready platform provides human-relevant barrier and neurological models designed for future regulatory alignment.
Key Capabilities
Strategic Platform Partnerships
Long-term collaborations for organizations seeking dedicated platform access.
The Decision Problem
Organizations need reliable partners who can support sustained drug development programs with consistent quality.
Current Shortcoming
Fee-for-service models lack the integration and continuity needed for strategic drug development initiatives.
How We Enable
We offer co-development partnerships with dedicated platform access, long-term data collaboration, and aligned incentives.
Key Capabilities
Find the Right Solution for Your Program
Every drug development challenge is unique. Let's discuss how our platform can support your specific needs.